Scan to Download Gate App
qrCode
More Download Options
Don't remind me again today

Sonnet Biotherapeutics, operating in the biotech field, has made a significant move in the crypto world. A merger agreement with Rorschach, the treasury management collective of the Hyperliquid ecosystem backed by Paradigm, has been put on the table. This step marks a new structure at the intersection of traditional biotechnology and decentralized finance protocols. Market observers assess that such hybrid models may increase in the upcoming period.

HYPE6.17%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • 4
  • Repost
  • Share
Comment
0/400
HashRateHustlervip
· 17h ago
Are these biotech companies starting to play with DeFi now? That's interesting.
View OriginalReply0
blocksnarkvip
· 17h ago
Biotechnology combined with Decentralized Finance? This combo is a bit wild, but there is still something behind Paradigm.
View OriginalReply0
GovernancePretendervip
· 17h ago
Biotech and DeFi really need to combine, this trend is a bit wild.
View OriginalReply0
GasFeeCryvip
· 17h ago
Biotech combined with crypto, this combination is pretty powerful... but is Rorschach reliable?
View OriginalReply0
  • Pin
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)